PERSPECTA

News from every angle

← Back to headlines

Stock Analysis: Biopharmaceutical Play Incyte Poised for Breakout

Shares of biopharmaceutical company Incyte are showing signs of a breakout, moving out of a seven-month trading range, according to analyst Carter Worth.

26 Jun, 18:18 — 26 Jun, 18:18
PostShare

Sources

Showing 1 of 1 sources
cnbcMostly Factual52d ago

A breakout could be in the cards for this biopharmaceutical play, says Carter Worth

Shares of Incyte are now moving out of a seven-month range.

Read full article →

Related Stories

Netflix Stock Valuation Debate: Undervalued or Value Trap?

39m ago

Ferrari's First Electric Car, Luce, Sells for Record $40 Million at Auction

1h ago

OpenAI Investors Consider Latest CFO Comments

1h ago

Synchrony Partners with OpenAI for AI Shopping Integration

1h ago